Paratek Pharmaceuticals Inc


Paratek Pharmaceuticals Inc (PTRK) Well on the Way to Broad Market Opportunity Following Successful Phase 3 for Omadacycline

Paratek Pharmaceuticals Inc (NASDAQ:PRTK) shares rose by nearly 31% after the microcap acne medicine maker announced a positive top-line Phase 3 data readout …

Monday’s Market Insights: Cyclacel Pharmaceuticals Inc (CYCC), DryShips Inc. (DRYS), New Concept Energy, Inc. (GBR), Paratek Pharmaceuticals Inc (PRTK)

Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) is the big winner today – largely thanks to optimism surrounding the company’s cancer drug candidate, CYC065. The company just …

Paratek Pharmaceuticals Inc (PRTK) Scores a Home Run with Sarecycline Phase 3

Paratek Pharmaceuticals Inc (NASDAQ:PRTK) shares are rising 11% today after the biotech firm and its collaborator Allergan posted a successful Phase 3 data …

Cantor Sees CAPB Advantage for Paratek Pharmaceuticals Inc (PRTK) in Wake of Cempra Inc (CEMP) CRL Setback

Cantor analyst Chiara Russo is liking the odds for Paratek Pharmaceuticals Inc (NASDAQ:PRTK) after Cempra Inc (NASDAQ:CEMP) received a Complete Response Letter (CRL) …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts